Trials / Unknown
UnknownNCT06037213
A Real-World Patient-Reported Outcomes Study in Patients With Long-Term Use of Niraparib
Non-interventional Study to Collect Real-world Patient-Reported Outcomes Data in Platinum-Sensitive Relapsed Ovarian Cancer Patients With Long-Term Use of Niraparib
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Peking Union Medical College Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This prospective, non-interventional study is designed to evaluate the quality of life of Chinese ovarian cancer patients with long-term niraparib use in a real-world setting. Participants will complete questionnaires or accept telephone follow-up to provide information about their quality of life.
Detailed description
In this prospective, non-interventional study, patients with platinum-sensitive relapsed ovarian cancer who have received niraparib as maintenance therapy for more than two years will agree to be contacted by questionnaire or telephone three times. The interval will be 4-6 weeks. Information on quality of life will be collected and analysed.
Conditions
Timeline
- Start date
- 2023-08-23
- Primary completion
- 2023-12-31
- Completion
- 2024-01-31
- First posted
- 2023-09-14
- Last updated
- 2023-09-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06037213. Inclusion in this directory is not an endorsement.